Home > Insider Trading > Filing (0000908662-11-000003)

Filing Details

Accession Number:: 0000908662-11-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-01-21 16:42:27
Reporting Period:: 2011-01-19

Filing Date:: 2011-01-21
Accepted Time:: 2011-01-21 16:42:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
737207	Marina Biotech Inc.	MRNA	Pharmaceutical Preparations (2834)	112658569

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1114448	Ag Novartis	Lichtstrasse 35 Basel V8 4002		No	No	Yes	No
1297709	Ltd Bioventures Novartis	131 Front Street Hamilton D0 HM 12		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2011-01-19	10,900	$1.50	2,888,170	No	4	S	Direct
Common Stock	Disposition	2011-01-19	2,900	$1.51	2,885,270	No	4	S	Direct
Common Stock	Disposition	2011-01-19	6,400	$1.52	2,878,870	No	4	S	Direct
Common Stock	Disposition	2011-01-19	600	$1.52	2,878,270	No	4	S	Direct
Common Stock	Disposition	2011-01-19	500	$1.53	2,877,770	No	4	S	Direct
Common Stock	Disposition	2011-01-19	3,300	$1.53	2,874,470	No	4	S	Direct
Common Stock	Disposition	2011-01-19	8,400	$1.54	2,866,070	No	4	S	Direct
Common Stock	Disposition	2011-01-19	400	$1.55	2,865,670	No	4	S	Direct
Common Stock	Disposition	2011-01-19	8,600	$1.56	2,857,070	No	4	S	Direct
Common Stock	Disposition	2011-01-19	700	$1.58	2,856,370	No	4	S	Direct
Common Stock	Disposition	2011-01-19	100	$1.59	2,856,270	No	4	S	Direct
Common Stock	Disposition	2011-01-20	1,000	$1.22	2,855,270	No	4	S	Direct
Common Stock	Disposition	2011-01-20	800	$1.23	2,854,470	No	4	S	Direct
Common Stock	Disposition	2011-01-20	1,800	$1.24	2,852,670	No	4	S	Direct
Common Stock	Disposition	2011-01-20	2,100	$1.25	2,850,570	No	4	S	Direct
Common Stock	Disposition	2011-01-20	2,700	$1.26	2,847,870	No	4	S	Direct
Common Stock	Disposition	2011-01-20	1,000	$1.27	2,846,870	No	4	S	Direct
Common Stock	Disposition	2011-01-20	200	$1.29	2,846,670	No	4	S	Direct
Common Stock	Disposition	2011-01-20	2,000	$1.30	2,844,670	No	4	S	Direct
Common Stock	Disposition	2011-01-20	2,500	$1.31	2,842,170	No	4	S	Direct
Common Stock	Disposition	2011-01-20	1,943	$1.32	2,840,227	No	4	S	Direct
Common Stock	Disposition	2011-01-20	2,057	$1.33	2,838,170	No	4	S	Direct
Common Stock	Disposition	2011-01-20	2,700	$1.35	2,835,470	No	4	S	Direct
Common Stock	Disposition	2011-01-20	208	$1.37	2,835,262	No	4	S	Direct
Common Stock	Disposition	2011-01-20	6,292	$1.38	2,828,970	No	4	S	Direct
Common Stock	Disposition	2011-01-20	4,500	$1.39	2,824,470	No	4	S	Direct
Common Stock	Disposition	2011-01-20	5,200	$1.40	2,819,270	No	4	S	Direct
Common Stock	Disposition	2011-01-20	1,500	$1.41	2,817,770	No	4	S	Direct
Common Stock	Disposition	2011-01-20	2,800	$1.42	2,814,970	No	4	S	Direct
Common Stock	Disposition	2011-01-20	4,400	$1.43	2,810,570	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares are directly owned by Novartis Bioventures Ltd. Novartis Bioventures Ltd. is a wholly-owned indirect subsidiary of Novartis AG, which is an indirect beneficial owner of the reported securities.
Transactions continued on a subsequent Form 4 due to limitations on the number of reportable transactions.